Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

NCT00691470 is registered in ClinicalTrials.gov with ARYx Therapeutics as lead sponsor.

NCT NCT00691470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00691470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
Lead sponsor
ARYx Therapeutics
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 31, 2008
Completion date
June 30, 2009
Enrollment
600 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial flutter, cardiomyopathy, myocardial infarction, venous thromboembolic disease